Acadian Asset Management LLC Chimerix Inc Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Chimerix Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,188,482 shares of CMRX stock, worth $1.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,188,482

Previous 2,174,813 0.63%

Holding current value

$1.93 Million

Previous $1.9 Million 6.78%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.77 - $1.07 $10,525 - $14,625	13,669 Added 0.63%	2,188,482 $2.03 Million
Q1 2024 May 10, 2024	BUY	$0.91 - $1.26 $265,702 - $367,896	291,981 Added 15.51%	2,174,813 $2.3 Million
Q4 2023 Feb 13, 2024	SELL	$0.9 - $1.06 $143,145 - $168,594	-159,051 Reduced 7.79%	1,882,832 $1.81 Million
Q2 2023 Aug 07, 2023	BUY	$1.1 - $1.54 $57,402 - $80,363	52,184 Added 2.62%	2,041,883 $2.47 Million
Q1 2023 May 11, 2023	BUY	$1.19 - $2.09 $1.13 Million - $1.98 Million	947,259 Added 90.87%	1,989,699 $2.51 Million
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.35 $1.74 Million - $2.45 Million	1,042,440 New	1,042,440 $1.94 Million
Q2 2021 Aug 11, 2021	SELL	$7.54 - $9.79 $2.48 Million - $3.22 Million	-328,788 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$4.76 - $11.25 $1.37 Million - $3.23 Million	-286,955 Reduced 46.6%	328,788 $3.17 Million
Q4 2020 Feb 11, 2021	SELL	$2.43 - $5.42 $392,007 - $874,354	-161,320 Reduced 20.76%	615,743 $2.97 Million
Q3 2020 Nov 09, 2020	SELL	$2.3 - $3.72 $581,394 - $940,341	-252,780 Reduced 24.55%	777,063 $1.94 Million
Q2 2020 Aug 12, 2020	BUY	$1.33 - $3.63 $74,759 - $204,042	56,210 Added 5.77%	1,029,843 $3.19 Million
Q1 2020 May 11, 2020	BUY	$1.27 - $2.33 $160,444 - $294,358	126,334 Added 14.91%	973,633 $1.4 Million
Q4 2019 Feb 06, 2020	BUY	$1.3 - $2.72 $354,914 - $742,589	273,011 Added 47.54%	847,299 $1.72 Million
Q3 2019 Nov 07, 2019	BUY	$1.93 - $4.21 $33,309 - $72,660	17,259 Added 3.1%	574,288 $1.35 Million
Q2 2019 Aug 08, 2019	BUY	$2.05 - $4.32 $152,667 - $321,719	74,472 Added 15.43%	557,029 $2.41 Million
Q1 2019 May 09, 2019	BUY	$1.79 - $3.12 $444,637 - $775,011	248,401 Added 106.08%	482,557 $1.01 Million
Q4 2018 Feb 07, 2019	BUY	$2.24 - $3.9 $40,024 - $69,685	17,868 Added 8.26%	234,156 $601,000
Q3 2018 Oct 30, 2018	BUY	$3.58 - $4.9 $219,171 - $299,982	61,221 Added 39.48%	216,288 $841,000
Q2 2018 Jul 24, 2018	BUY	$4.43 - $5.14 $266,185 - $308,847	60,087 Added 63.26%	155,067 $738,000
Q1 2018 Apr 12, 2018	BUY	$4.65 - $5.9 $160,745 - $203,957	34,569 Added 57.22%	94,980 $494,000
Q4 2017 Jan 18, 2018	BUY	$4.32 - $5.52 $260,975 - $333,468	60,411	60,411 $280,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

37M

Call Options Held

52.7K

Put Options Held

130K

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $77.1M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Chimerix Inc Transaction History